This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Institut National De La Sante Et De La Recherche Medicale, Université Paris-Saclay. Active years: 2026.
Company Filing History:
1 out of 11 
1 out of 98 
Years Active: 2026
Title: The Innovative Contributions of Roger Sun in Cancer Research
Introduction
Roger Sun is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer research through his innovative inventions. His work focuses on developing advanced imaging tools that enhance the understanding of tumor behavior and patient outcomes.
Latest Patents
Roger Sun holds a patent for a radiomics-based imaging tool designed to monitor tumor-lymphocyte infiltration and outcomes in cancer patients treated with anti-PD-1/PD-L1 therapies. This invention proposes a radiomics-based biomarker that detects the presence and density of tumor-infiltrating CD8 T-cells in solid tumors without the need for biopsies. Furthermore, it aims to utilize this information to assess the immune phenotype of solid tumors, ultimately prognosing the survival and treatment efficiency of cancer patients undergoing immunotherapy.
Career Highlights
Throughout his career, Roger Sun has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris-Saclay. His experience in these organizations has allowed him to collaborate with leading experts in the field of medical research.
Collaborations
Roger has collaborated with notable colleagues, including Charles Ferte and Eric Deutsch, who have contributed to his research endeavors.
Conclusion
Roger Sun's innovative work in developing a radiomics-based imaging tool represents a significant advancement in cancer research. His contributions have the potential to improve patient outcomes and enhance the understanding of tumor dynamics.